Evaluation of the Effects of systemic Therapy on Inflammatory Markers and Disease Severity in Patients With Pemphigus
Introduction: In recent years, various inflammatory markers that can change in inflammatory states have been investigated. On the basis of these, we thought that inflammatory markers could also be used in the treatment of pemphigus disease and monitoring its activity. Objective: In this study, ou...
Saved in:
Main Authors: | Mehmet Enes Güner, Perihan Ozturk, Mine müjde Kuş |
---|---|
Format: | Article |
Language: | English |
Published: |
Mattioli1885
2025-01-01
|
Series: | Dermatology Practical & Conceptual |
Subjects: | |
Online Access: | https://dpcj.org/index.php/dpc/article/view/4969 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Two Patients with Therapy-Resistant Pemphigus Vulgaris and Severe Underlying Disease Showing Good Response to a New IVIg Preparation
by: Katharina Hogrefe, et al.
Published: (2025-01-01) -
A retrospective cohort study of biosimilar rituximab therapy in pemphigus: experience from a tertiary care hospital in North India
by: Sabha Mushtaq, et al.
Published: (2024-11-01) -
Immunosuppressive therapy of patients with pemphigus with ineffectiveness of systemic corticosteroids
by: Vadim V. Chikin, et al.
Published: (2024-12-01) -
Prognostic Factors Predicting Remission Following Rituximab Therapy for Pemphigus Vulgaris
by: Tal Raviv, et al.
Published: (2025-01-01) -
Consensus Based Indian Guidelines for the Management of Pemphigus Vulgaris and Pemphigus Foliaceous
by: Dipankar De, et al.
Published: (2025-01-01)